fashion -WSS

fashion

author：leisure time 2025-09-27 13:09:55 - browse：6498

Two $1 bills stapled together to make the shape of a heart against a red background. -- health policy coverage from STAT — Adobe

WASHINGTON — Doctors lowered the incidence of heart disease and strokes among their patients when Medicare rewarded them for focusing on sicker patients, according to research of a pilot program released Tuesday in the Journal of the American Medical Association. The pilot program didn’t increase overall costs at all.

The five-year pilot program is one of many that Medicare has run since the Affordable Care Act created an office to test whether Medicare payment policies can influence doctors in ways that keep patients healthier. That Obama-era initiative has not worked out as well as was hoped, but the Million Hearts Cardiovascular Disease Risk Reduction Model is one of the initiative’s bright spots.

Medicare paid doctors in the pilot program to assess the risk of heart problems, then Medicare paid them to focus on sicker patients. The pilot paid doctors more when they improved such measurements as blood pressure and cholesterol levels for sicker patients.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： The science behind Janet Jackson's pregnancy at 49

knowledge

WSS

How a scoliosis diagnosis changed the life of one young dancer

What would happen to your eyes if you looked at the solar eclipse?

White House finalizes ITC's import ban of latest Apple Watches

3 hurdles to bringing medical devices to the U.S. market

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

focus

fashion

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

With FDA staff opposed to Sarepta therapy, top official intervened

What does generative AI mean for health care? We asked experts

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Wildfire smoke exposes gaps in outdoor worker protections

Disclosing genetic information: not as worrisome as once feared

Guidelines to prevent youth baseball injuries need more muscle

Burning questions for the 2024 JPM Healthcare Conference

Hollywood unions extend contract negotiations for actors

Antibiotic resistance and the global rise in human conflict

knowledge

Federal weight loss drug coverage is 30 years out of date

CDC concerned about possible undetected monkeypox spread in U.K.

3 hurdles to bringing medical devices to the U.S. market

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Feng Zhang, Grail founder join forces on new gene editing startup

3 medical device trends to watch in 2024

knowledge

explore

hotspot

entertainment